Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Curve Therapeutics logo

Curve Therapeutics

Recent Finacing

Series A

Recent Raise

$51.4M

Curve Therapeutics develops an intracellular Microcycle® platform to screen hexameric cyclic peptide libraries in mammalian cells, convert hits to small molecules, and advance oncology HIF/ATIC inhibitor programs with MSD.

Founded 2019
Southampton, United Kingdom
11-50
Private
curvetx.com

Highlights

Focus Areas

Biotechnology

Recent Investors

Columbus Venture Partners logo
Pfizer Ventures logo
Epidarex Capital logo
Advent Life Sciences logo
British Patient Capital logo

Financials

$51.4M

Total Raised

1

Funding round

5

Investors


Team

Upgrade to view the team

See the team members at Curve Therapeutics.